Travere Therapeutics to Report Third Quarter 2025 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

The webcast and dial-in information can be accessed on the Investor page of Travere’s website at https://ir.travere.com/events-and-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251023110159/en/

Media:
888-969-7879
[email protected]

Investors:
888-969-7879
[email protected]

Source: Travere Therapeutics, Inc.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Crypto Market Rotation Watch: VOIDTRACE AI Targets the Data Gap Between Major Assets, AI Tokens and Presales
• Moody’s Reaffirms WSFS Financial Corp’s Baa2 Issuer Rating with a Positive Outlook; Reflects Diversified Business Model, Strong Capital, and Earnings Strength